These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Mecha M, Feliú A, Iñigo PM, Mestre L, Carrillo-Salinas FJ, Guaza C. Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307 [Abstract] [Full Text] [Related]
23. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. Brown DA, Sawchenko PE. J Comp Neurol; 2007 May 10; 502(2):236-60. PubMed ID: 17348011 [Abstract] [Full Text] [Related]
24. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment. Lapointe BM, Herx LM, Gill V, Metz LM, Kubes P. Brain; 2004 Dec 10; 127(Pt 12):2649-56. PubMed ID: 15355874 [Abstract] [Full Text] [Related]
25. Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Luccarini I, Ballerini C, Biagioli T, Biamonte F, Bellucci A, Rosi MC, Grossi C, Massacesi L, Casamenti F. Exp Neurol; 2008 May 10; 211(1):214-26. PubMed ID: 18346732 [Abstract] [Full Text] [Related]
26. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. Prasad R, Giri S, Nath N, Singh I, Singh AK. J Neurosci Res; 2006 Aug 15; 84(3):614-25. PubMed ID: 16770773 [Abstract] [Full Text] [Related]
27. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis. Li O, Liu JQ, Zhang H, Zheng P, Liu Y, Bai XF. Scand J Immunol; 2006 Aug 15; 64(2):117-24. PubMed ID: 16867156 [Abstract] [Full Text] [Related]
28. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. Engelhardt B. J Neurol Sci; 2008 Nov 15; 274(1-2):23-6. PubMed ID: 18573502 [Abstract] [Full Text] [Related]
29. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483 [Abstract] [Full Text] [Related]
30. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. Coisne C, Mao W, Engelhardt B. J Immunol; 2009 May 15; 182(10):5909-13. PubMed ID: 19414741 [Abstract] [Full Text] [Related]
31. Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node. Carrière V, Colisson R, Jiguet-Jiglaire C, Bellard E, Bouche G, Al Saati T, Amalric F, Girard JP, M'Rini C. Cancer Res; 2005 Dec 15; 65(24):11639-48. PubMed ID: 16357175 [Abstract] [Full Text] [Related]
32. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q. J Neuroimmunol; 2009 Jan 03; 206(1-2):58-69. PubMed ID: 19081144 [Abstract] [Full Text] [Related]
33. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis. Weir C, McNeill A, Hook S, Harvie M, La Flamme AC, Le Gros G, Bäckström BT. J Neuroimmunol; 2006 Oct 03; 179(1-2):18-25. PubMed ID: 16904193 [Abstract] [Full Text] [Related]
34. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis. Genoud S, Maricic I, Kumar V, Gage FH. J Neuroimmunol; 2005 Nov 03; 168(1-2):40-5. PubMed ID: 16120466 [Abstract] [Full Text] [Related]
35. Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: an intravital microscopic study. Lacerda-Queiroz N, Lima OC, Carneiro CM, Vilela MC, Teixeira AL, Teixeira-Carvalho A, Araújo MS, Martins-Filho OA, Braga EM, Carvalho-Tavares J. Acta Trop; 2011 Nov 03; 120(1-2):31-9. PubMed ID: 21722620 [Abstract] [Full Text] [Related]
36. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. J Neuroimmunol; 2008 Aug 13; 199(1-2):83-93. PubMed ID: 18582952 [Abstract] [Full Text] [Related]
37. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R. Eur J Immunol; 2009 Jun 13; 39(6):1671-81. PubMed ID: 19499521 [Abstract] [Full Text] [Related]
38. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R. J Neuroimmunol; 2006 Mar 13; 172(1-2):27-37. PubMed ID: 16337691 [Abstract] [Full Text] [Related]
39. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein. Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T. Exp Neurol; 2006 Mar 13; 198(1):136-44. PubMed ID: 16423348 [Abstract] [Full Text] [Related]
40. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice. Allameh A, Maleklou N, Zargari M, Sanati MH. Neurosci Lett; 2008 Jul 04; 439(1):111-5. PubMed ID: 18501514 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]